LEBANON, Ind. (WTHI) – Eli Lilly has announced a $5.3 billion investment at the LEAP Research and Innovation District in Lebanon, doubling the company’s investment at the site.
The announcement came Friday during the Indiana Global Economic Summit. The investment will expand the company’s ability to make ingredients for Type 2 diabetes and obesity medicines.
“We are excited about Eli Lilly and Company’s plan to expand their investment in Lebanon, reinforcing their role as a key community partner in driving future innovation and economic prosperity,” said Lebanon Mayor Matt Gentry. “Their investment underscores our shared commitment to creating greater opportunities and enhancing the quality of life for our residents and community.”
Eli Lilly broke ground at LEAP in April 2023. The company transformed a significant portion of its 600 acres at the site into an active construction site. Eli Lilly expects to begin making medicines there in late 2026.
The company also committed to creating another 200, new full-time jobs for highly skilled workers. Those positions would include engineers, scientists, operating personnel, and lab technicians.
The LEAP District as a whole has stirred controversy over land prices, as well as a water pipeline.